|
|
| | DOPEXAMINE Basic information |
| Product Name: | DOPEXAMINE | | Synonyms: | 4-[2-[[6-[(2-Phenylethyl)amino]hexyl]amino]ethyl]-1，2-benzenediol;DOPEXAMINE;4-[2-[[6-(Phenethylamino)hexyl]amino]ethyl]-1,2-benzenediol;1,2-Benzenediol, 4-(2-((6-((2-phenylethyl)amino)hexyl)amino)ethyl)-;86484-91-5 (Di-hydrochloride);Dopexamina;Dopexamina [spanish];Dopexaminum | | CAS: | 86197-47-9 | | MF: | C22H32N2O2 | | MW: | 356.5 | | EINECS: | | | Product Categories: | | | Mol File: | 86197-47-9.mol |  |
| | DOPEXAMINE Chemical Properties |
| Boiling point | 546.7±50.0 °C(Predicted) | | density | 1.081±0.06 g/cm3(Predicted) | | storage temp. | 2-8°C(protect from light) | | pka | 9.65±0.10(Predicted) |
| | DOPEXAMINE Usage And Synthesis |
| Description | Dopexamine is a dopamine analog useful in the treatment of acute congestive heart
failure. Its biochemical actions include the stimulation of beta2 and peripheral dopamine
receptors, as well as the inhibition of neuronal uptake of norepinephrine. The resultant
effect is an increase in cardiac output mediated by afterload reduction, increased blood
flow and positive inotropism following iv infusion. | | Originator | Fisons (United Kingdom) | | Uses | Cardiovascular agent. | | Definition | ChEBI: Dopexamine is a catecholamine. | | Brand name | Dopacard |
| | DOPEXAMINE Preparation Products And Raw materials |
|